Homology of HIV-1 Indian subtype C tat gene with other subtypes correlates with the induction of potent cross clade immune responses following immunization with HIV-1 Indian subtype C mutated and codon optimized tat DNA/MVA vaccine in mice
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Presence of anti-Tat immune responses in HIV infected individual's correlates inversely
with the progression of disease. Thus, we focused on the phylogeny & immunogenicity
of Indian subtype C tat gene. In this study full length HIV-1 tat gene was amplified
and sequenced. Based on sequencing data HIV-1 Indian subtype Ctat gene consensus sequence
was derived, mutated & codon optimized. This modified tat gene consensus was used
to construct tat DNA/MVA vaccine. Immunogenicity of tat DNA/MVA vaccine was studied
in mice and immune responses were evaluated by IFNg ELISpot assay and ELISA. Our tat
study sequences depicted maximum homology with HIV-1 subtype C. DNA distances of tat
study sequences with consensus sequences of subtype M, C, B&A were 8–10%, 4–6%, 19–21%
& 11–18% respectively. Mice immunized with tat DNA construct alone developed potent
cross clade T cell & antibodyresponses. Magnitude of these immune responses was increased
3 folds in mice immunized with tat DNA/MVA prime boost regimen. Immunogenic regions
of Indian subtype CTat protein localize at amino acid (aa)1–20, aa 16–35, aa 31–50,
aa 67–86. Core region(aa 31–50) of Indian subtype CTat protein was found to be immunodominant.
In this scenario HIV-1 Indiansubtype Ctat gene appears to be a suitable candidate
for future multigene HIV vaccine.